Stay updated on TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page.

Latest updates to the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new Revision: v3.6.4 tag was added, replacing Revision: v3.6.3, indicating a small platform update rather than changes to the study details.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedFooter revision updated from v3.6.2 to v3.6.3, signaling a new site version deployment. This update does not alter study information or page content.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page's site revision was updated from v3.6.0 to v3.6.2, indicating a minor platform update. The change appears in the footer as a version tag and does not alter the study information shown.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page adds separate entries for the investigator and sponsoring institution (HW Kapiteijn and Leiden University Medical Center) and introduces new navigation links such as How to Read a Study Record, Common Questions, and How to Join a Study. It also updates the status/verification labels and changes the label formatting for Intervention/Treatment, plus updates the revision/version from v3.5.5 to v3.6.0.SummaryDifference1%

- Check59 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, reflecting a new metadata version of the page. This appears to be a minor maintenance update with no changes to the study details, eligibility criteria, or displayed content.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision: v3.5.4 was added and Revision: v3.5.3 was removed, updating the page's version label. This change updates the page's version indicator without altering substantive content.SummaryDifference0.1%

Stay in the know with updates to TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page.